Home Search Abstracts Browse Sessions Program Committee E-mail Abstract Author View Session


Session 26 Oral Abstracts
Retroviral Pathogenesis
Wednesday, 10 am - 12:30 pm
Presentation Time: 10:15 am
Room 2005


122
Identification of a Gene Product, Murr1, that Restricts HIV-1 Replication in Primary Resting CD4+ T-lymphocytes
L Ganesh*1, E Burstein1, A Guha-Niyogi1, M K Louder1, J R Mascola1, L W J Klomp2, C Wijmenga2, C S Duckett3, and G Nabel1
1Vaccine Res. Ctr., NIAID, NIH, DHHS, Bethesda, MD, USA; 2Univ. Med. Ctr. Utrecht, Netherlands; and 3Univ. of Michigan, Ann Arbor, USA

Background:  Although HIV-1 infects quiescent and proliferating CD4+ lymphocytes, the virus replicates poorly in resting T cells. Factors that block viral replication in these cells may help to prolong the asymptomatic phase of HIV infection; however, the molecular mechanisms that control this process are not fully understood.

Results:  In this study, we report that Murr1, a gene product known previously for its involvement in copper regulation, inhibits HIV-1 growth in unstimulated CD4+ T cells. This inhibition was mediated, in part, through its ability to inhibit basal and cytokine-stimulated NF-kB activity. Knock-down of Murr1 increased NF-kB activity and decreased IkB-a levels by facilitating phospho-IkB-a degradation by the proteasome. Murr1 was detected in CD4+ T cells, and importantly, RNA-mediated interference of Murr1 in primary resting CD4+ lymphocytes increased HIV-1 replication.

Conclusions:  Through its effects on the proteasome, Murr1 acts as a genetic restriction factor that inhibits HIV-1 replication in resting lymphocytes, which could contribute to the regulation of asymptomatic HIV infection and the progression of AIDS.

Keywords: Murr1